A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAFV600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer
Josep Tabernero*, Eric Van Cutsem, Elena Garralda, David Tai, Filippo De Braud, Ravit Geva, Mark T.J. van Bussel, Katia Fiorella Dotti, Elena Elez, María J. De Miguel, Kevin Litwiler, Danielle Murphy, Michelle Edwards, Van Karlyle Morris
Research output: Contribution to journal › Article › peer-review
22Scopus
citations
Fingerprint
Dive into the research topics of 'A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAFV600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer'. Together they form a unique fingerprint.